Similar articles for PMID: 15865101

Year	Number of Results
1997	3
1998	1
1999	3
2000	6
2001	12
2002	8
2003	6
2004	10
2005	14
2006	10
2007	14
2008	13
2009	5
2010	3
2011	3
2012	3
2013	3
2015	2
2016	2
2017	2
2019	3
2024	0

1

Triplet chemotherapy with docetaxel, gemcitabine and liposomal doxorubicin, supported with subcutaneous amifostine and hemopoietic growth factors, in advanced non-small cell lung cancer.

Patlakas G, Bouros D, Tsantekidou-Pozova S, Koukourakis MI. Patlakas G, et al. Anticancer Res. 2005 Mar-Apr;25(2B):1427-31. Anticancer Res. 2005. PMID: 15865101 Free article. Clinical Trial.

2

Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study.

Casal J, Amenedo M, Mel JR, Antón LM, Rodríguez-López R, López-López R, González-Ageitos A, Castellanos J, Constenla M, Tisaire JL. Casal J, et al. Cancer Chemother Pharmacol. 2007 Oct;60(5):725-32. doi: 10.1007/s00280-007-0418-7. Epub 2007 Feb 2. Cancer Chemother Pharmacol. 2007. PMID: 17273825 Clinical Trial.

3

Combination chemotherapy with carboplatin, docetaxel, and gemcitabine in advanced non-small-cell lung cancer: a phase II study.

Pectasides D, Aspropotamitis A, Halikia A, Visvikis A, Antoniou F, Kalantaridou A, Karvounis N, Batzios S, Athanassiou A. Pectasides D, et al. J Clin Oncol. 1999 Dec;17(12):3816-21. doi: 10.1200/JCO.1999.17.12.3816. J Clin Oncol. 1999. PMID: 10577854 Clinical Trial.

4

Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor.

Hejna M, Kornek GV, Raderer M, Ulrich-Pur H, Fiebiger WC, Marosi L, Schneeweiss B, Greul R, Scheithauer W. Hejna M, et al. Cancer. 2000 Aug 1;89(3):516-22. Cancer. 2000. PMID: 10931450 Clinical Trial.

5

Concurrent administration of Docetaxel and Stealth liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection.

Koukourakis MI, Romanidis K, Froudarakis M, Kyrgias G, Koukourakis GV, Retalis G, Bahlitzanakis N. Koukourakis MI, et al. Br J Cancer. 2002 Aug 12;87(4):385-92. doi: 10.1038/sj.bjc.6600486. Br J Cancer. 2002. PMID: 12177774 Free PMC article. Review.

6

Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.

Cobo Dols M, Villar Chamorro E, Alés Díaz I, Gil Calle S, Alcalde García J, Gutiérrez Calderón V, Carabantes Ocón F, Montesa Pino A, Bretón García JJ, Benavides Orgaz M. Cobo Dols M, et al. Clin Transl Oncol. 2006 Oct;8(10):742-9. doi: 10.1007/s12094-006-0121-x. Clin Transl Oncol. 2006. PMID: 17074673 Clinical Trial.

7

Second line therapy with weekly low-dose docetaxel for pretreated non-small-cell lung carcinoma patients: a multicenter Italian phase II study.

Ardizzoia A, Acquati M, Fagnani D, Giordano M, Visini M, Scanni A, Quattrone A, Fusco O, Vergani C, Casartelli C, Tagliabue P, Malugani F; POLONORD Group. Ardizzoia A, et al. Lung. 2004;182(1):1-8. doi: 10.1007/s00408-003-1039-5. Lung. 2004. PMID: 14752667 Clinical Trial.

8

Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.

Kosmas C, Tsavaris N, Vadiaka M, Stavroyianni N, Koutras A, Malamos N, Onyenadum A, Rokana S, Polyzos A, Kalofonos HP. Kosmas C, et al. Cancer. 2001 Dec 1;92(11):2902-10. doi: 10.1002/1097-0142(20011201)92:11<2902::aid-cncr10103>3.0.co;2-o. Cancer. 2001. PMID: 11753965 Clinical Trial.

9

Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.

Kakolyris S, Papadakis E, Tsiafaki X, Kalofonos C, Rapti A, Toubis M, Bania E, Kouroussis C, Chainis K, Androulakis N, Agelaki S, Sarra E, Vardakis N, Georgoulias V; Greek Cooperative Group for Lung Cancer. Kakolyris S, et al. Lung Cancer. 2001 May;32(2):179-87. doi: 10.1016/s0169-5002(00)00212-9. Lung Cancer. 2001. PMID: 11325489 Clinical Trial.

10

Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial.

Georgoulias V, Papadakis E, Alexopoulos A, Tsiafaki X, Rapti A, Veslemes M, Palamidas P, Vlachonikolis I; Greek Oncology Cooperative Group (GOCG) for Lung Cancer. Georgoulias V, et al. Lancet. 2001 May 12;357(9267):1478-84. doi: 10.1016/S0140-6736(00)04644-4. Lancet. 2001. PMID: 11377599 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year